Výsledky vyhledávání - "Anne Marie Boesen"

Pre-Emptive Treatment With Rituximab of Molecular Relapse After Autologous Stem Cell Transplantation in Mantle Cell Lymphoma

Autor: Erkki Elonen, Marie Nordström, Jaan Väärt, Mats Jerkeman, Niels Smedegaard Andersen, Mikael Eriksson, Grete F. Lauritzsen, Beatrice Malmer, Anna Laurell, Roald Ekanger, Lone Bredo Pedersen, Lars Møller Pedersen, Anne Marie Boesen, Christian H. Geisler, Herman Nilsson-Ehle, Susanne Fredén, Arne Kolstad

Publikováno v: Andersen, N S, Pedersen, L B, Laurell, A, Elonen, E, Kolstad, A, Boesen, A M, Pedersen, L M, Lauritzsen, G F, Ekanger, R, Nilsson-Ehle, H, Nordström, M, Fredén, S, Jerkeman, M, Eriksson, M, Väärt, J, Malmer, B & Geisler, C H 2009, ' Pre-emptive treatment with rituximab of molecular relapse after autologous stem cell transplantation in mantle cell lymphoma ', Journal of Clinical Oncology, vol. 27, no. 26, pp. 4365-70 . https://doi.org/10.1200/JCO.2008.21.3116

Purpose Minimal residual disease (MRD) is predictive of clinical progression in mantle-cell lymphoma (MCL). According to the Nordic MCL-2 protocol we prospectively analyzed the efficacy of pre-emptive treatment using rituximab to MCL patients in mole

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a47da6558110f4c4db43f5dd1e4f192
https://doi.org/10.1200/jco.2008.21.3116

Zobrazit plný text záznamu

Subclassification in Acute Lymphoblastic Leukaemia: Acid Phosphatase Reaction and Immunological Markers in Relation to Clinical Features

Autor: Lissi Bank Lassen, Jørgen Ellegaard, Anne Marie Boesen, Peter Hokland

Publikováno v: Europe PubMed Central

A prospective, comparative study of cytochemical and immunological markers and clinical features was undertaken in 44 patients with ALL (children and adults). 12 patients (27%) had T-ALL, 1 patient (2%) B-ALL and 31 patients (71%) (non-T, non-B)-All.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::230bb9427b5541b7a7e3dd8be453e4ce
https://doi.org/10.1111/j.1600-0609.1981.tb00457.x

Zobrazit plný text záznamu

Ultrastructural localization of acid alpha-naphthylacetate esterase in human normal and neoplastic lymphocytic and monocytic cells and in hairy cells

Autor: Anne Marie Boesen

Publikováno v: Scandinavian Journal of Haematology. 32:367-375

The ultrastructural localization of acid alpha-naphthylacetate esterase (ANAE) activity was studied in normal and neoplastic human monocytic and lymphocytic cells including hairy cells. Normal monocytes and malignant monocytic cells from cases of AML

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e65c299fd4363adcbe7e31339d05cf27
https://doi.org/10.1111/j.1600-0609.1984.tb00690.x

Zobrazit plný text záznamu

Acid phosphatase and acid esterase activity in neoplastic and non-neoplastic lymphoid cells A semiquantitative evaluation related to immunological markers in 112 cases

Autor: Peter Hokland, O. Myhre Jensen, Anne Marie Boesen

Publikováno v: Europe PubMed Central

Acid phosphatase (AcP) and acid alpha-naphthylacetate esterase (ANAE) were examined in lymphoid cells from 104 patients suffering from various lymphoproliferative disorders and from 8 healthy controls. Enzyme activities were evaluated by means of a s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a8d288343ca1a8aa6a472194684b0c5
https://doi.org/10.1111/j.1600-0609.1984.tb01697.x

Zobrazit plný text záznamu

Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo–purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group

Publikováno v: Blood. 112:2687-2693

Mantle cell lymphoma (MCL) is considered incurable. Intensive immunochemotherapy with stem cell support has not been tested in large, prospective series. In the 2nd Nordic MCL trial, we treated 160 consecutive, untreated patients younger than 66 year

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f62ffe47753420d1c3cb904d83db1eb
https://doi.org/10.1182/blood-2008-03-147025

Zobrazit plný text záznamu

Final analysis of the UKLG LY02 trial comparing 6-8 cycles of CHOP with 3 cycles of CHOP followed by a BEAM autograft in patients65 years with poor prognosis histologically aggressive NHL

Autor: Lynny Yung, Paul Smith, Marek Trneny, David C. Linch, Peter Browett, Anne Marie Boesen, Harald Holte, David Cunningham, Peter Hoskin, Ken MacLennan, Andrew Jack, Wendi Qian, Andrew Grigg, Barry W. Hancock

Publikováno v: British journal of haematology. 149(2)

P>This trial involved 457 patients and sought to assess the value of early intensification with autologous transplantation in patients with poor prognosis histologically aggressive non-Hodgkin lymphoma (NHL) showing a response to initial CHOP (cyclos

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e39c19bfc5c1d3160f09ce7cb26d66c
https://pubmed.ncbi.nlm.nih.gov/20201949

Zobrazit plný text záznamu

[Acute lymphoblastic leukaemia in Danish children and young people 10 to 19 years of age. Should young adults with acute lymphoblastic leukaemia be treated in the same way as children?]

Autor: Henrik, Schrøder, Marthe, Kjeldstad, Anne Marie, Boesen, Ove Juul, Nielsen, Kai Gjerløff, Schmidt, Hans Erik, Johnsen, Henrik, Gregersen, Göran, Gustafsson

Publikováno v: Ugeskrift for laeger. 168(26-32)

Data seem to indicate that young adults with acute lymphoblastic leukemia (ALL) have a better survival rate when treated with paediatric protocols than with adult ALL protocols. The purpose of this study was to report the clinical characteristics and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7cbe40221b72e518299875001d759030
https://pubmed.ncbi.nlm.nih.gov/16824410

Zobrazit plný text záznamu

Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma

Autor: Martin, Hutchings, Annika, Loft, Mads, Hansen, Lars M, Pedersen, Anne Kiil, Berthelsen, Susanne, Keiding, Francesco, D'Amore, Anne-Marie, Boesen, Lone, Roemer, Lena, Specht

Publikováno v: Haematologica. 91(4)

In order to receive the most appropriate therapy, patients with Hodgkin's lymphoma (HL) must be accurately stratified into different prognostic staging groups. Computed tomography (CT) plays a pivotal role in the conventional staging. The aim of the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::115d37933591d7ad43688cafb607789b
https://pubmed.ncbi.nlm.nih.gov/16585010

Zobrazit plný text záznamu

FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma

Autor: Lena Specht, Francesco d'Amore, Anne-Marie Boesen, Annika Loft, Martin Hutchings, Thora Buhl, Anne Kiil Berthelsen, Simon Buus, Susanne Keiding, Lars Møller Pedersen, Jesper Jurlander, Mads Hansen

Publikováno v: Hutchings, M, Loft, A, Hansen, M, Pedersen, L M, Buhl, T, Jurlander, J, Buus, S, Keiding, S, D'Amore, F, Boesen, A-M, Berthelsen, A K & Specht, L 2006, ' FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma. ', Blood, vol. 107, no. 1, pp. 52-9 . https://doi.org/10.1182/blood-2005-06-2252

Risk-adapted lymphoma treatment requires early and accurate assessment of prognosis. This investigation prospectively assessed the value of positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose (FDG-PET) after two cycles of chemotherapy f

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a346b0f16504e46f1d9fe0c417462e4b
https://pubmed.ncbi.nlm.nih.gov/16150944

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání